EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis

Ching-Reigh Hsieh, Chyi-Liang Chen, Chia-Jung Kuo, Ren-Chin Wu, Pai-Jui Yeh, Chien-Ming Chen, Cheng-Tang Chiu, Cheng-Hsun Chiu, Ming-Yao Su, Ming-Ling Chang, Yuan-Ming Yeh, Yu-Bin Pan und 1 weitere

International Journal of Colorectal Disease · 2025

DOI: 10.1007/s00384-025-04954-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2025. Verfasst von Ching-Reigh Hsieh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Guei-Shan District, 5, Fu-Hsin Street, Taoyuan City, Linkou, 33305, Taiw…. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Inflammatory Bowel Diseases, Coinfection, Colitis. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) colitis and Clostridioides difficile infection (CDI) are both linked to disease exacerbation and poor prognosis in patients with inflammatory bowel disease (IBD). Nonetheless, the effect of co-infection on clinical outcomes in individuals with IBD remains underexplored. This retrospective study was designed to assess the clinical outcomes and determine predictors of co-infection with CMV and CDI in individuals with IBD.

Methods

This analysis involved hospitalized patients with IBD and confirmed CMV colitis (based on intestinal CMV immunohistochemical staining) and Clostridioides difficile toxin A/B test results, collected at the Linkou branch of Chang Gung Memorial Hospital between January 2001 and September 2023. The individuals in the study cohort were divided into two categories: those with CMV infection alone and those with CMV/CDI co-infection. Clinical manifestations, outcomes, and independent predictors of co-infection were assessed between the two groups.

Results

Overall, 53 IBD inpatients were enrolled in this study, with 37 assigned to the CMV group and 16 to the CMV/CDI co-infection group. The co-infection group experienced significantly more diarrhea (54.1% vs. 93.8%, p = 0.005) and abdominal pain (54.1% vs. 87.5%, p = 0.020) compared to the CMV group. Hospitalization duration (1 vs. 2.5 admissions, p = 0.005) and CMV recurrence (0 vs. 1 recurrences, p < 0.001) were higher in the co-infection group. Additionally, co-infection prolonged the time to clinical (1 vs. 5 months, p < 0.001), steroid-free (4 vs. 10 months, p = 0.001), endoscopic (8.3 vs. 17.5 months, p = 0.011), and histological remission (11 vs. 18 months, p = 0.021) compared to CMV infection alone. The cumulative incidence of clinical, steroid-free, endoscopic, and histological remission showed a delayed course in the co-infection group. Multivariable analysis revealed that biologic therapy was an independent predictor for CMV/CDI co-infection (OR 13.33, 95% CI 1.52–117.15, p = 0.02).

Conclusion

Co-infection of CMV and CDI among individuals with IBD results in more frequent hospitalizations, higher CMV recurrence rates, and prolonged disease remission compared to CMV colitis alone. The administration of biologic therapy increases the risk of co-infection, emphasizing the importance of careful management in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsInflammatory Bowel DiseasesCoinfectionColitisClostridium InfectionsClostridioides difficileHumansFemaleMalePrognosisAdultMiddle AgedRetrospective Studies

Stichwörter der Autor:innen

Clostridioides difficileClinical remissionCytomegalovirusInflammatory bowel diseaseOpportunistic infection

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Guei-Shan District, 5, Fu-Hsin Street, Taoyuan City, Linkou, 33305, Taiwan.
  • Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Linkou, Taiwan.
  • Chang Gung Inflammatory Bowel Disease Center, Taoyuan, Linkou, Taiwan.
  • Chang Gung Microbiota Therapy Center, Taoyuan, Taiwan.
  • Taiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan.
  • Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan, Linkou, Taiwan.

Zitieren

APA

Hsieh, C. R., Chen, C. L., Kuo, C. J., Wu, R. C., Yeh, P. J., Chen, C. M., Chiu, C. T., Chiu, C. H., Su, M. Y., Chang, M. L., Yeh, Y. M., Pan, Y. B., & Le, P. H. (2025). Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-025-04954-2

Vancouver

Hsieh CR, Chen CL, Kuo CJ, Wu RC, Yeh PJ, Chen CM, et al. Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis. International Journal of Colorectal Disease. 2025. doi:10.1007/s00384-025-04954-2

BibTeX
@article{Hsieh2025,
  author = {Hsieh, Ching-Reigh and Chen, Chyi-Liang and Kuo, Chia-Jung and Wu, Ren-Chin and Yeh, Pai-Jui and Chen, Chien-Ming and Chiu, Cheng-Tang and Chiu, Cheng-Hsun and Su, Ming-Yao and Chang, Ming-Ling and Yeh, Yuan-Ming and Pan, Yu-Bin and Le, Puo-Hsien},
  title = {Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis},
  journal = {International Journal of Colorectal Disease},
  year = {2025},
  doi = {10.1007/s00384-025-04954-2}
}
Kostenlos starten →